Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie.
Hosted on MSN10mon
Boston Scientific’s stock heads for record high as earnings shine and company offers upbeat guidanceBoston Scientific Corp.’s stock rose 7% Wednesday ... with rapid adoption from both RF and cryo users,” Mahoney told analysts on the company’s earnings call, according to a FactSet transcript.
1d
Zacks Investment Research on MSNIs Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?Boston Scientific’s BSX fourth-quarter 2024 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive strategic ...
The Food and Drug Administration issued a notice on Friday classifying its recall of the Boston Scientific Accolade pacemaker devices as the most serious type of recall. To date, 832 injuries and ...
(RTTNews) - Boston Scientific Corp. (BSX), Monday announced its decision to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS Intravascular Ultrasound System.
Boston Scientific stock (NYSE: BSX) has gained 3% in the five days since its Q4 earnings report last week. Although the company exceeded expectations with both its results and guidance ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results